11. Myasthenia
226 clinical trials,   172 drugs   (DrugBank: 45 drugs),   43 drug target genes,   118 drug target pathways

Searched query = "Myasthenia", "MG"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2014-001355-23-NL
(EUCTR)
29/08/201414/05/2014Ephedrine as add-on therapy for patients with myasthenia gravisEphedrine as add-on therapy for patients with myasthenia gravis - Ephedrine for MG myasthenia gravis
MedDRA version: 17.0;Level: PT;Classification code 10028417;Term: Myasthenia gravis;System Organ Class: 10029205 - Nervous system disorders;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
Trade Name: Hidrocloruro de efedrina
INN or Proposed INN: EPHEDRINE HYDROCHLORIDE
Other descriptive name: EPHEDRINE HYDROCHLORIDE
Leiden University Medical CenterNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
Netherlands
2NCT00541216
(ClinicalTrials.gov)
October 20077/10/2007Ephedrine for the Treatment of Congenital MyastheniaMyasthenic Syndromes, CongenitalDrug: EphedrineHadassah Medical OrganizationNULLEnrolling by invitation12 Years75 YearsBoth15Phase 1;Phase 2Israel